Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-30

Clinical Trial Update: A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II [NA]

View source ↗

Summary

A Phase II trial of a novel iron-based supplement for athletes aged 18-25, sponsored by the University of Calgary; the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novel iron-based supplement

Snippet

Sponsor: University of Calgary | Conditions: Iron Deficiencies | NA | Status: ACTIVE_NOT_RECRUITING